Sloy Dahl & Holst’s Merck MRK Stock Holding History

Sloy Dahl & Holst’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-2,920	Closed	-$266K	–	78
2022 Q2	$266K	Hold	2,920	–	–	0.06%	57
2022 Q1	$239K	Buy	+2,920	New	+$230K	0.04%	68

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Sloy Dahl & Holst's MRK Position: Q3 2022 in Review

Sloy Dahl & Holst sold out of Merck (MRK) in Q3 2022, closing a stake of 2,920 shares — an estimated $266K sold.

Sloy Dahl & Holst first reported a position in MRK in Q1 2022 and held it in 2 quarters. The position peaked at $266K in Q2 2022. 2,989 funds tracked by Wall St. Rank hold MRK as of Q3 2022.

Sloy Dahl & Holst reported no remaining Merck position as of Q3 2022 after selling out during the quarter.
Sloy Dahl & Holst sold 2,920 Merck shares in Q3 2022, an estimated $266K.
Sloy Dahl & Holst first reported a position in Merck in Q1 2022 and held it in 2 quarters.
Sloy Dahl & Holst's Merck position peaked at $266K in Q2 2022.
2,989 funds tracked by Wall St. Rank held Merck as of Q3 2022.

Based on Sloy Dahl & Holst's 13F filing for Q3 2022, filed 19 Oct 2022.